CeriBell (NASDAQ:CBLL) Sees Large Volume Increase – Time to Buy?

CeriBell, Inc. (NASDAQ:CBLL) shares saw an uptick in trading volume on Thursday . Approximately 429,632 shares changed hands during trading, an increase of 31% from the previous session’s volume of 326,995 shares.The stock last traded at $19.9860 and had previously closed at $20.00.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on CBLL shares. Weiss Ratings upgraded shares of CeriBell from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Monday. Canaccord Genuity Group reduced their target price on CeriBell from $28.00 to $25.00 and set a “buy” rating for the company in a research note on Tuesday, May 12th. One equities research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $22.20.

CeriBell Trading Down 1.4%

The stock has a 50-day moving average of $18.84 and a 200 day moving average of $19.73. The stock has a market cap of $748.43 million, a PE ratio of -12.12 and a beta of 0.84. The company has a quick ratio of 10.01, a current ratio of 10.44 and a debt-to-equity ratio of 0.14.

CeriBell (NASDAQ:CBLL) last posted its quarterly earnings results on Monday, May 11th. The company reported ($0.52) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.39) by ($0.13). CeriBell had a negative return on equity of 38.19% and a negative net margin of 63.51%.The business had revenue of $26.49 million for the quarter, compared to analysts’ expectations of $26.09 million. As a group, sell-side analysts anticipate that CeriBell, Inc. will post -1.69 earnings per share for the current year.

Insider Buying and Selling at CeriBell

In related news, major shareholder Tpg Gp A, Llc sold 202,368 shares of the firm’s stock in a transaction on Friday, June 26th. The shares were sold at an average price of $20.12, for a total transaction of $4,071,644.16. Following the completion of the transaction, the insider owned 3,765,054 shares of the company’s stock, valued at $75,752,886.48. This trade represents a 5.10% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Xingjuan Chao sold 39,000 shares of the business’s stock in a transaction on Monday, June 8th. The shares were sold at an average price of $18.33, for a total transaction of $714,870.00. Following the transaction, the chief executive officer owned 816,317 shares of the company’s stock, valued at $14,963,090.61. This represents a 4.56% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 348,582 shares of company stock worth $6,843,905 over the last ninety days. 20.10% of the stock is owned by insiders.

Hedge Funds Weigh In On CeriBell

Institutional investors and hedge funds have recently modified their holdings of the stock. Bank of America Corp DE boosted its stake in shares of CeriBell by 15.3% in the first quarter. Bank of America Corp DE now owns 319,837 shares of the company’s stock worth $5,863,000 after buying an additional 42,340 shares during the last quarter. Quantinno Capital Management LP raised its position in CeriBell by 3.0% during the first quarter. Quantinno Capital Management LP now owns 140,347 shares of the company’s stock valued at $2,573,000 after acquiring an additional 4,119 shares in the last quarter. Sei Investments Co. lifted its holdings in CeriBell by 2.3% in the first quarter. Sei Investments Co. now owns 50,360 shares of the company’s stock valued at $923,000 after acquiring an additional 1,125 shares during the period. State of Wyoming purchased a new stake in CeriBell in the 1st quarter worth approximately $62,000. Finally, KCM Capital Inc boosted its position in CeriBell by 40.0% in the 1st quarter. KCM Capital Inc now owns 1,400,000 shares of the company’s stock worth $25,662,000 after purchasing an additional 400,000 shares in the last quarter.

CeriBell Company Profile

CeriBell Corp (NASDAQ: CBLL) is a healthcare technology company specializing in the design, manufacture and sale of automated newborn hearing screening devices. The company offers a suite of medical diagnostic tools based on otoacoustic emissions (OAE) and auditory brainstem response (ABR) technologies, enabling early detection of auditory impairments in infants. CeriBell’s solutions are used in hospitals, birthing centers and audiology clinics to support universal newborn hearing screening programs aimed at improving language development outcomes through prompt intervention.

The company’s product portfolio includes handheld and desktop screening units, proprietary software for data management, and accessories designed to streamline testing workflows.